Blueflite has joined the University of Michigan’s Mcity mobility ecosystem and received funding through the Michigan Mobility Funding Platform to support a pilot program exploring autonomous aircraft for time-sensitive organ transportation.
The Brighton, Michigan-based drone logistics company is working with M-air, the University of Michigan’s advanced air mobility initiative, and Michigan Medicine on the project. Funding was provided through the Michigan Department of Transportation’s Office of Future Mobility and Electrification as blueflite became a founding member of M-air, an expansion of the Mcity public-private advanced mobility partnership.
The pilot is designed to demonstrate how autonomous aircraft could improve the transportation of donated organs between medical facilities. Organ transplant logistics can involve ground vehicles, helicopters, and other transportation networks that may be affected by traffic, aircraft availability, distance, and other operational constraints.
Blueflite plans to use its modular tiltrotor uncrewed aircraft system to support transportation between medical facilities using beyond visual line of sight, or BVLOS, capabilities. M-air will support airspace integration and BVLOS operations, while Michigan Medicine will serve as the clinical partner and transplant recipient site.
Initial testing and validation are expected to take place at the Mcity Test Facility. The partners intend to develop an infrastructure and operational framework that could potentially be replicated elsewhere in Michigan.
Blueflite plans to conduct at least 20 end-to-end demonstration missions. The program will evaluate flight and delivery times, reliability, system performance, safety, and medical payload conditions.
The project is targeting at least a 30% reduction in last-mile organ transportation time compared with historical ground transportation benchmarks. The team is also targeting a mission completion reliability rate of at least 95%.
Payload monitoring will be a major component of the testing process. The program will collect continuous temperature data as well as information about vibration, shock exposure, and chain of custody. Those records will be evaluated alongside aircraft flight logs and hospital dispatch information.
The pilot will also examine how autonomous aircraft could fit into existing hospital workflows, regulatory requirements, safety processes, dispatch operations, and coordination with first responders and traditional transportation resources.
Founded in 2018, blueflite provides a drone-based logistics platform using aircraft designed and assembled in the United States. The company joins other organizations working with M-air on advanced air mobility initiatives, including AG3 Labs, Airspace Link, the Michigan National Guard, Pierce Aerospace, and the Wayne County Airport Authority.
The project’s final phase will assess operational and economic performance and recommend potential deployment elsewhere in Michigan. Similar infrastructure could eventually support transportation of blood components, tissue, laboratory samples, and other time-sensitive medical supplies, particularly between healthcare facilities in areas where conventional transportation can take considerably longer.
KEY QUOTES:
“M-air is building the enabling structure for blueflite and Michigan Medicine to operate, with funding from the Michigan Department of Transportation. We’ll end up with an infrastructure blueprint MDOT can duplicate in other locations to support organ transfer across the state of Michigan.”
Greg McGuire, Managing Director Of Mcity
“Whether it’s an organ for transplant to an academic medical center or critical blood components urgently needed at a rural site, time is of the essence. Minutes lost to traffic or logistical bottlenecks directly impact organ viability and patient outcomes. Partnering with Mcity and blueflite allows Michigan Medicine to build and validate an airspace delivery pipeline that could improve care delivery in the future.”
Dr. Florian Schmitzberger, Clinical Assistant Professor Of Emergency Medicine At The University Of Michigan Medical School
“Joining Mcity gives blueflite the opportunity to work within one of Michigan’s strongest mobility ecosystems and bring together the technology, infrastructure, clinical expertise and regulatory coordination needed to make autonomous medical logistics a reality. This grant allows us to continue moving beyond demonstrating what the aircraft can do and continue validating how the entire system can operate in a real-world healthcare environment. Our goal is to prove a safe, reliable and scalable model for transporting time-critical medical payloads, that can ultimately be replicated across Michigan and beyond.”
Tyler Bruder, Business Development Lead At Blueflite

